Last reviewed · How we verify
Low dose omega-3 fatty acid supplementation
Low dose omega-3 fatty acid supplementation is a Small molecule drug developed by Zhejiang University. It is currently in Phase 1 development. Also known as: Fish oil supplement.
At a glance
| Generic name | Low dose omega-3 fatty acid supplementation |
|---|---|
| Also known as | Fish oil supplement |
| Sponsor | Zhejiang University |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
- Gastrointestinal
- Infectious
- Psychological
- Nose
- Sleep
- Chest
- Energy
- Ear
- Muscular
- Skin
- Eye
- Genital
Key clinical trials
- Omega-3 Supplementation and Mental Health in College Students (NA)
- Long-Term Omega-3 and Omega-3 Index >8%: Effects on Physiological Recovery (NA)
- Enteral High-dose DHA Supplementation on Bronchopulmonary Dysplasia in Very Preterm Infants: a Collaborative Study (NA)
- Hepatoprotective Measures for Children at High Risk of NAFLD (PHASE4)
- Hepatoprotective for Children and Adolescent With Acute Lymphoblastic Leukemia (PHASE4)
- Effectiveness of Nutrition Education Program and Omega-3 Supplementation Among Non-alcoholic Fatty Liver Disease Patients (NA)
- The Effect of Omega-3 FA on Glucose and Lipid Homeostasis Disorders in Obese/Diabetic Patients (NA)
- Omega-3 Fatty Acid Supplementation and Tear Film Quality in Celiac Patients (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Low dose omega-3 fatty acid supplementation CI brief — competitive landscape report
- Low dose omega-3 fatty acid supplementation updates RSS · CI watch RSS
- Zhejiang University portfolio CI
Frequently asked questions about Low dose omega-3 fatty acid supplementation
What is Low dose omega-3 fatty acid supplementation?
Low dose omega-3 fatty acid supplementation is a Small molecule drug developed by Zhejiang University.
Who makes Low dose omega-3 fatty acid supplementation?
Low dose omega-3 fatty acid supplementation is developed by Zhejiang University (see full Zhejiang University pipeline at /company/zhejiang-university).
Is Low dose omega-3 fatty acid supplementation also known as anything else?
Low dose omega-3 fatty acid supplementation is also known as Fish oil supplement.
What development phase is Low dose omega-3 fatty acid supplementation in?
Low dose omega-3 fatty acid supplementation is in Phase 1.
What are the side effects of Low dose omega-3 fatty acid supplementation?
Common side effects of Low dose omega-3 fatty acid supplementation include Gastrointestinal, Infectious, Psychological, Nose, Sleep, Chest.
Related
- Manufacturer: Zhejiang University — full pipeline
- Also known as: Fish oil supplement
- Compare: Low dose omega-3 fatty acid supplementation vs similar drugs
- Pricing: Low dose omega-3 fatty acid supplementation cost, discount & access